CNS Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)19holders
1famous investor
$0.36avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding CNS Pharmaceuticals Inc. in their 13F filings. The largest holders were Armistice Capital, LLC ($171K), Virtu Financial LLC ($34K) and Citadel Advisors ($33K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- CNS Pharmaceuticals Inc.
- CUSIP
- 18978H201
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $58K |
| Exits | 1 | $14K |
Ownership 19 holders
| Armistice Capital, LLC | 0.00% | Add +286.1% | 471,000 | $171K |
| Virtu Financial LLC | 0.00% | Add +616.6% | 94,246 | $34K |
| Citadel Advisors | 0.00% | New | 91,034 | $33K |
| Smith Anglin Financial, LLC | 0.00% | Add +80.7% | 90,332 | $33K |
| Vanguard Group Inc. | 0.00% | No change | 58,369 | $21K |
| Geode Capital Management, LLC | 0.00% | Add +15.6% | 28,254 | $10K |
| Jane Street Group, LLC | 0.00% | New | 27,388 | $10K |
| State Street Corp. | 0.00% | No change | 22,556 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 21,806 | $8K |
| HRT Financial LP | 0.00% | New | 21,898 | $7K |
| FSM Wealth Advisors, LLC | 0.00% | No change | 19,084 | $7K |
| XTX Topco Ltd | 0.00% | Add +87.3% | 18,729 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +70.4% | 6,772 | $2K |
| Bank of America Corp. | 0.00% | Add +77800.0% | 779 | $282 |
| Wells Fargo & Company | 0.00% | Add +16.4% | 241 | $87 |
| Morgan Stanley | 0.00% | No change | 67 | $24 |
| Global Retirement Partners, LLC | 0.00% | No change | 53 | $19 |
| FMR LLC | 0.00% | Reduce -93.4% | 14 | $5 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CNS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of CNS Pharmaceuticals Inc. the manager owns.